Circulating Tumor DNA Detection in Early-Stage Non-Small Cell Lung Cancer Patients by Targeted Sequencing

Circulating tumor DNA (ctDNA) isolated from peripheral blood has recently been shown to be an alternative source to detect gene mutations in primary tumors; however, most previous studies have focused on advanced stage cancers, and few have evaluated ctDNA detection in early-stage lung cancer. In th...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ke-Zhong, Lou, Feng, Yang, Fan, Zhang, Jing-Bo, Ye, Hua, Chen, Wei, Guan, Tian, Zhao, Ming-Yu, Su, Xue-Xia, Shi, Rong, Jones, Lindsey, Huang, Xue F., Chen, Si-Yi, Wang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995492/
https://www.ncbi.nlm.nih.gov/pubmed/27555497
http://dx.doi.org/10.1038/srep31985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995492/
https://www.ncbi.nlm.nih.gov/pubmed/27555497
http://dx.doi.org/10.1038/srep31985

Ejemplares similares